Abstract
Background:
In Australia, molecular point-of-care testing(POCT) for chlamydia(CT), gonorrhoea(NG) and trichomonas(TV) has been programmatically implemented since 2016 in regional and remote Aboriginal and Torres Strait Islander communities. POCT is community-led and delivered through primary care clinics, often located significant distances from centralised laboratories. We evaluated POCT program reach and testing uptake to understand the individual and public health impact.
In Australia, molecular point-of-care testing(POCT) for chlamydia(CT), gonorrhoea(NG) and trichomonas(TV) has been programmatically implemented since 2016 in regional and remote Aboriginal and Torres Strait Islander communities. POCT is community-led and delivered through primary care clinics, often located significant distances from centralised laboratories. We evaluated POCT program reach and testing uptake to understand the individual and public health impact.
Original language | English |
---|---|
Number of pages | 2 |
Publication status | Published - 19 Sept 2024 |
Event | 25th IUSTI World Congress incorporating the Australasian Sexual and Reproductive Health Conference 2024: IUSTI 2024 - ICC Sydney, Sydney, Australia Duration: 17 Sept 2024 → 20 Sept 2024 |
Conference
Conference | 25th IUSTI World Congress incorporating the Australasian Sexual and Reproductive Health Conference 2024 |
---|---|
Country/Territory | Australia |
City | Sydney |
Period | 17/09/24 → 20/09/24 |
Keywords
- Point-of-Care (POC) testing
- sexually transmitted infections
- Aboriginal Torres Strait Islander
- remote Australia